Literature DB >> 26163452

Pioglitazone ameliorates methotrexate-induced renal endothelial dysfunction via amending detrimental changes in some antioxidant parameters, systemic cytokines and Fas production.

Sahar M El-Gowilly1, Mai M Helmy2, Hanan M El-Gowelli1.   

Abstract

Methotrexate (MTX) is widely used in treatment of cancers and autoimmune diseases. However, nephrotoxicity is one of its most important side effects. The peroxisome proliferator-activated receptor gamma agonist, pioglitazone, is known to exert antiinflammatory and reno-protective effects in various kidney injuries. The purpose of this study was to investigate the potential involvement of endothelial damage in MTX-induced renal injury and to elaborate the possible protective effect of pioglitazone against MTX-induced endothelial impairment. Compared with saline-treated rats, treatment with MTX (7mg/kg for 3days) caused significant elevations in serum levels of urea and creatinine, increased renal nitrate/nitrite level and impaired renovascular responsiveness of isolated perfused kidney to endothelium-dependent vasodilations induced by acetylcholine (0.01-2.43nmol) and isoprenaline (1μmol). These effects were abolished by concurrent treatment with pioglitazone (2.5mg/kg, for 5days starting 2days before MTX). Alternatively, MTX treatment did not affect endothelium-independent renovascular relaxation induced by sodium nitroprusside (0.001-10μmole). The possibility that alterations in renal antioxidants, circulating cytokine and apoptotic factor (Fas) levels contributed to MTX-pioglitazone interaction was assessed. Pioglitazone treatment abrogated renal oxidative stress (decreased reduced glutathione and catalase activity and increased malondialdehyde), elevated serum cytokine (interleukin-6, interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta1) and Fas induced by MTX. Histologically, MTX caused defused tubular cells swelling and vacuolization associated with endothelial damage in renal arterioles. These effects disappeared upon co-treated with pioglitazone. Collectively, pioglitazone abolished MTX-induced endothelium dysfunction and nephrotoxicity via ameliorating oxidative stress and rectifying cytokines and Fas abnormalities caused by MTX.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelium; Kidney; Methotrexate; Pioglitazone

Mesh:

Substances:

Year:  2015        PMID: 26163452     DOI: 10.1016/j.vph.2015.07.002

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  3 in total

1.  The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.

Authors:  Qiuying Zhao; Xiaohui Wu; Shuo Yan; Xiaofang Xie; Yonghua Fan; Jinqiang Zhang; Cheng Peng; Zili You
Journal:  J Neuroinflammation       Date:  2016-10-04       Impact factor: 8.322

2.  Ginkgo Biloba Extract Alleviates Methotrexate-Induced Renal Injury: New Impact on PI3K/Akt/mTOR Signaling and MALAT1 Expression.

Authors:  Iman O Sherif; Nora H Al-Shaalan; Dina Sabry
Journal:  Biomolecules       Date:  2019-11-03

Review 3.  Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate.

Authors:  Arduino A Mangoni; Sara Tommasi; Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Matteo Piga; Gian Luca Erre
Journal:  Drugs Context       Date:  2018-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.